Elsevier’s Oncology Journal Network highlights

Cancer Letters

• SLC4A4 is a novel driver of enzalutamide resistance in prostate cancer

Cancer Pathogenesis and Therapy

• Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study

• NEPC-associated CEP55 promotes cisplatin resistance in prostate cancer by regulating CDK1 phosphorylation

Cancer Treatment and Research Communications

• Assessing knowledge, attitude and practice towards prostate cancer screening among males in Southwest Tanzania: A cross-sectional study

Clinical Genitourinary Cancer

• Antibody-Drug Conjugates in Prostate Cancer: Where Are we?

• Targeted Biopsy in Men High Risk for Prostate Cancer: 68Ga-PSMA PET/CT Versus mpMRI

Clinical Oncology

• Patterns of Failure After Prostate-Only Radiotherapy in High-Risk Prostate Cancer: Implications for Refining Pelvic Nodal Contouring Guidelines

Clinical Surgical Oncology

• The effectiveness and safety of stereotactic body radiotherapy (SBRT), proton therapy (PT), and irreversible electroporation (IRE) for localized prostate cancer

Critical Reviews in Oncology / Hematology

• Prostate-specific membrane antigen as target for vasculature-directed therapeutic strategies in solid tumors

• Warming-up the immune cell engagers (ICEs) era in breast cancer: state of the art and future directions

Current Problems in Cancer

• Advances in high-risk localized prostate cancer: Staging and management

European Journal of Cancer

• Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in England

• Radiological progression-free survival as a surrogate for overall survival in patients with metastatic hormone-sensitive prostate cancer: A bivariate meta-analysis

International Journal of Particle Therapy

• "Worst-Case Robustness Evaluation Methods for IMPT: A Critical Comparison"

International Journal of Radiation Oncology, Biology, Physics

• Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomy

• Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)

Journal of Geriatric Oncology

• Geriatric determinants of curative radiotherapy scheme choice for older adults with breast cancer treatment compliance and tolerance: Results from the GERABEL study

• Localized prostate cancer in older patients: Radical prostatectomy or radiotherapy versus observation

The Journal of Liquid Biopsy

• Genomic characterization of metastatic patterns in prostate cancer using circulating tumor DNA data from the SCRUM-Japan MONSTAR SCREEN project

• ctDNA-based liquid biopsy reveals wider mutational profile with therapy resistance and metastasis susceptibility signatures in early-stage breast cancer patients

Journal of the National Cancer Center

• Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer

• Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer

Magnetic Resonance Imaging

• Longitudinal quantitative MRI in prostate cancer after radiation therapy with and without androgen deprivation therapy

• The impact of benign tissue within cancerous regions in the prostate: Characterizing sparse and dense prostate cancers on whole-mount histopathology and on multiparametric MRI

Neoplasia

• Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization

Oral Oncology

• Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer

Practical Radiation Oncology

• Clinician- and Patient-Reported Outcomes of Stereotactic Ablative Radiation Therapy for High-Risk Prostate Cancer

• Volumetric Changes and Acute Toxicity with 68Ga Prostate-Specific Membrane Antigen vs 18F-Fluciclovine PET/CT Guided Post-Prostatectomy Radiation: Final Analysis of a Randomized Trial

Radiotherapy and Oncology

• The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trial

• Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective study

Radiation Medicine and Protection

• Neoadjuvent androgen deprivation for seminal vesicle reduction: The optimal portion of seminal vesicle included in the high-dose CTV in localized prostate cancer radiotherapy

Seminars in Oncology

• Breaking barriers: Deciphering the mechanisms of Olaparib resistance in prostate cancer

• Prostate cancer in Türkiye: Trend analysis of incidence and mortality rates

Seminars in Ultrasound, CT, and MRI

• Role of MRI in Active Surveillance of Prostate Cancer

• The Role of Prostate-Specific Membrane Antigen-Radioligand and Magnetic Resonance Imaging in Patients with Prostate Cancer Biochemical Recurrence

Elsevier’s Oncology Journal Network